share_log
Moomoo 24/7 ·  03/11 07:47

Sonnet BioTherapeutics Shares Are Trading Higher After the Company's Phase 1b/2a Clinical Trial of SON-080 Was Cleared to Proceed to Phase 2 After Review by an Independent DSMB

Sonnet BioTherapeutics股價走高,此前該公司的 SON-080 1b/2a期臨床試驗經獨立DSMB審查後獲准進入第二階段

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論